Novel Bacterial-Based System for Diagnosing Gastrointestinal Conditions

Introduction to Innovative Diagnostic Tool

Researchers at the Massachusetts Institute of Technology (MIT) have created an oral pill that has the potential to transform the diagnosis and management of gastrointestinal conditions. This breakthrough aims to replace painful endoscopic procedures that are traditionally used to identify serious gastrointestinal issues such as drug-induced bleeding or ulcers.

The Need for Non-Invasive Diagnostic Methods

Current diagnostic practices often involve the use of endoscopes, which are small cameras attached to long tubes that are inserted through the mouth or rectum. As there is a growing demand for less invasive methods to monitor gastrointestinal health, MIT’s innovative approach seeks to address this issue effectively.

Details of the Ingestible Capsule

The new diagnostic tool is an ingestible micro-bioelectronics device (IMBED) that contains bioengineered bacteria. These bacteria are securely housed within a small chamber, sandwiched between a porous membrane and an optical detector designed to capture light signals. The bacteria used are non-toxic and similar to those found in probiotic supplements that promote digestive health.

Testing the System Using a Pig Model

Extensive testing was conducted using a pig model to monitor gastric bleeding caused by the painkiller indomethacin. The bacterial biosensor was specifically engineered to detect heme, a protein that indicates excessive bleeding. Furthermore, the bacteria were modified to include a transporter that facilitates the internalization of this protein.

Wireless Transmission of Diagnostic Data

The bacteria within the capsule also carry a small DNA cassette linked to a gene that produces light. When heme binds to this DNA cassette, it activates the gene, resulting in the emission of bioluminescent light. In the absence of heme, the system remains inactive, producing no light. This light signal is detected by ultra-small optical sensors adjacent to the bacteria. The findings demonstrated precise detection of heme in pigs experiencing painkiller-induced bleeding. Additionally, the pill is equipped with small transmitters that wirelessly relay light signals to external devices, such as laptops or mobile phones.

Expanding Detection Capabilities

The researchers further optimized the system to identify other substances released in the gut under pathological conditions. For instance, the system successfully detected acyl homoserine lactone (AHL), a compound associated with bacterial infections in the gut, and thiosulfate, which is often elevated during gut inflammation. Notably, the sensor is capable of withstanding the acidic environment of the gastrointestinal tract. These results were published in the journal Science.

Future Research Directions

The authors of the study believe that such biosensors could provide significant advantages in situations where endoscopic access is limited. They also noted the potential to directly detect compounds in the gut that may break down quickly before being excreted. The research team is now focused on expanding the sensor’s capabilities to detect additional compounds and related medical conditions.

Miniaturization and Next Steps

Another area of ongoing research involves further miniaturizing the pill to facilitate easier ingestion. However, as the device is still in the early prototype testing phase, further preclinical and clinical evaluations will be necessary before it can be considered for commercial use in humans.

Conclusion

This pioneering research represents a significant advancement in non-invasive diagnostic techniques for gastrointestinal health, potentially changing how such conditions are monitored and managed in the future.

References

Mimee, M., Nadeau, P., Hayward, A., Carim, S., Flanagan, S., Jerger, L., … Lu, T. K. (2018). An ingestible bacterial-electronic system to monitor gastrointestinal health. Science, 360(6391), 915-918. doi:10.1126/science.aas9315